| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6166428 | Urology | 2015 | 5 Pages |
Abstract
No patient with a BT or ND biopsy developed a local recurrence with short-term follow-up, whereas a recurrence developed in 12.5% of biopsy-proven RCC tumors. RFS for patients with biopsy-proven RCC was worse than the other 2 biopsy groups, although not statistically significant. Long-term follow-up in a larger cohort of patients is needed to further evaluate these preliminary findings.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kara N. Babaian, Zhamshid Okhunov, Samuel Juncal, Michael Ordon, Achim Lusch, Tara Zand, Cassio Andreoni, Jaime Landman,